Drug application
NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE)
Drugs@FDA ANDA 065088 · SCIEGEN PHARMS
Key facts
| Drug name | NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC |
|---|---|
| Active ingredients | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE |
| Application type | ANDA |
| Application number | 065088 |
| Company | SCIEGEN PHARMS |
| Dosage forms | OINTMENT, OPHTHALMIC |
| Strength | 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM |
| Marketing status | Discontinued |
| TE codes | AT |
| Reference listed drug | No |
| Latest submission status date | Feb 6, 2004 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: